ANTX   $4.6  -1.08% Market Closed

AN2 Therapeutics, Inc.

EMA (20): 2026-04-17 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

EMA (50): 2026-03-04 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

EMA (100): 2026-03-04 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

RSI: RSI indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the positive territory it's higher than the signal line and falls. These factors mean that the growing trend persists, but the growth rate is declining. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: main and signal line crossing.

Trend Type turning up
Power strong
Trend Pattern
EMA (20) Signals bullish reversal
EMA (20) Yield 28.81%
EMA (20) date of signal April 17, 2026, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 247.01%
EMA (50) date of signal March 4, 2026, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 247.01%
EMA (100) date of signal March 4, 2026, 3 a.m.
RSI Signals bullish weakening
RSI (14) Yield -0.85%
RSI (14) date of signal May 5, 2026, 3 a.m.
MACD Signals bullish weakening
MACD Yield -0.85%
MACD date of signal May 5, 2026, 3 a.m.
Stochastic Signals bearish
Stochastic Yield 0.0
Stochastic date of signal May 6, 2026, 3 a.m.
Updated May 7, 2026, 11 p.m.